These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26041447)

  • 21. Atherosclerotic renal artery stenosis: where's Waldo?
    Whitlow PL
    JACC Cardiovasc Interv; 2008 Jun; 1(3):293-4. PubMed ID: 19463315
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis.
    Levenson DJ; Dzau VJ
    Kidney Int Suppl; 1987 May; 20():S173-9. PubMed ID: 3037167
    [No Abstract]   [Full Text] [Related]  

  • 23. Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular disease.
    Chade AR; Stewart NJ; Peavy PR
    Kidney Int; 2014 Apr; 85(4):833-44. PubMed ID: 24352153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volume and vasoconstriction in experimental renovascular hypertension.
    Freeman RH; Davis JO; Seymour AA
    Fed Proc; 1982 Jun; 41(8):2409-14. PubMed ID: 7044827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemic nephropathy/azotemic renovascular disease.
    Textor SC; Wilcox CS
    Semin Nephrol; 2000 Sep; 20(5):489-502. PubMed ID: 11022902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renovascular arterial hypertension: current aspects of physiopathology, diagnosis and treatment].
    Humke U; Ziegler M
    Ann Urol (Paris); 1997; 31(2):64-76. PubMed ID: 9245250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory and injury signals released from the post-stenotic human kidney.
    Eirin A; Gloviczki ML; Tang H; Gössl M; Jordan KL; Woollard JR; Lerman A; Grande JP; Textor SC; Lerman LO
    Eur Heart J; 2013 Feb; 34(7):540-548a. PubMed ID: 22771675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?
    Textor SC; Lerman LO
    J Am Soc Nephrol; 2015 Sep; 26(9):2074-80. PubMed ID: 25868641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.
    Lerman LO; Textor SC; Grande JP
    Prog Cardiovasc Dis; 2009; 52(3):196-203. PubMed ID: 19917330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension therapy in patients with renal artery stenosis].
    Vogt B; Maillard M; Burnier M
    Ther Umsch; 2012 May; 69(5):279-81. PubMed ID: 22547359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angiotensin-converting enzyme inhibitor renography. Physiopathological, diagnostic and therapeutic aspects in renal artery stenosis].
    Pedersen EB
    Ugeskr Laeger; 1994 Feb; 156(7):948-54, 957. PubMed ID: 8009737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
    Lastra G; Manrique C; Sowers JR
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of renovascular hypertension and therapeutic decisions.
    Vaughan ED; Case DB; Pickering TG; Sosa RE; Sos TA; Laragh JH
    Urol Clin North Am; 1984 Aug; 11(3):393-407. PubMed ID: 6205495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence-based medicine in renal artery stenting.
    Rabbia C; Pini R
    J Cardiovasc Surg (Torino); 2010 Oct; 51(5):755-63. PubMed ID: 20924335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renovascular hypertension: is it only the top of the iceberg?].
    Lewandowski J
    Pol Merkur Lekarski; 2003 Oct; 15(88):371-5; discussion 375-6. PubMed ID: 14974369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Hypoxia in Ischemic Chronic Kidney Disease.
    Textor SC; Lerman LO
    Semin Nephrol; 2019 Nov; 39(6):589-598. PubMed ID: 31836041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease.
    Nyvad J; Lerman A; Lerman LO
    Hypertension; 2022 Apr; 79(4):717-725. PubMed ID: 35135307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The microcirculation: a key player in obesity-associated cardiovascular disease.
    Sorop O; Olver TD; van de Wouw J; Heinonen I; van Duin RW; Duncker DJ; Merkus D
    Cardiovasc Res; 2017 Jul; 113(9):1035-1045. PubMed ID: 28482008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renovascular hypertension due to unilateral renal artery stenosis with hypokalemic alkalosis, the salt-losing syndrome and reversible hyperechogenicity of the contralateral kidney. A study of 2 infants].
    Castelló Girona F; Yeste Fernández D; Porta Ribera R; Enríquez Cívicos G
    An Esp Pediatr; 1996 Jul; 45(1):49-52. PubMed ID: 8849130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.